Copyright
©The Author(s) 2025.
World J Stem Cells. Dec 26, 2025; 17(12): 114076
Published online Dec 26, 2025. doi: 10.4252/wjsc.v17.i12.114076
Published online Dec 26, 2025. doi: 10.4252/wjsc.v17.i12.114076
Table 1 Summary of the effects of preconditioning methods on stem cells
| Ref. | Pretreatment method | Cell type | Effects on stem cells | Mechanism | Animal model |
| Song et al[21], 2017 | Mechanical stimulation | Rabbit BMSCs | Promote proliferation and differentiation | Increase collagen I, collagen III, ALP, OPN, tenascin C, and tenomodulin expression | Rabbit ACLR model |
| Wang et al[20], 2023 | Mechanical stimulation | Mouse BMSCs | Promote chondrogenic differentiation | Stimulate macrophage polarization towards the M2 phenotype and secretion of TGF-β1 | Mouse ACLR model |
| Li et al[17], 2015 | Mechanical stimulation | Rat BMSCs | Inhibit adipogenic differentiation | Activate the TGFβ1/Smad2 signaling pathway | N/A |
| Kusuyama et al[26], 2014 | LIPUS | Mouse MSCs line | Inhibit adipogenic differentiation, promote osteogenic differentiation | Regulate the ROCK-Cot/Tpl2-MEK-ERK signaling pathway and PPARγ2 activity | N/A |
| Chen et al[27], 2023 | LIPUS | hUC-MSCs | Promote chondrogenic differentiation | Inhibit the TNF signaling pathway | Rat cartilage defect model |
| Wang et al[28], 2019 | LIPUS | Rat BMSCs | Promote chondrogenic differentiation | Inhibit autophagy | N/A |
| Zhao et al[29], 2021 | ESW | Human SCB-SPCs | Promote self-renewal | Activate the YAP/TAZ signaling pathway | Rabbit osteochondral defect model |
| Chen et al[31], 2017 | ESW | Rat BMSCs | Promote proliferation and osteogenic differentiation | Increase Col1, OSX, Runx2, and ALP expression | Rat femoral shaft bone defect model |
| Hu et al[32], 2016 | ESW | Human BMSCs, TDSCs, ADSCs | Promote osteogenic differentiation | Inhibit miR-138 to activate the FAK-ERK1/2-RUNX2 signaling pathway | Nude mouse bone induction model |
| Catalano et al[33], 2017 | ESW | Human ADSCs | Promote osteogenic differentiation | Activate the ROS-ERK1/2-BMP2-Smad-RUNX2 signaling pathway | N/A |
| Wu et al[37], 2022 | SLPI | Rat BMSCs | Promote migration and osteogenic differentiation | Upregulate Runx2, ALP, OCN, and OPN gene expression | Rat ACLR model |
| Han et al[38], 2024 | TFRD | Mouse BMSCs | Promote vitality and osteogenic differentiation | Activate ERR1/2-Gga1-TGF-β/MAPK pathway | Rat ACLR model |
| Zhang et al[39], 2017 | PVP-I | Rabbit BMSCs | Promote osteogenic differentiation | Increase the expression of BMP-2 and OPN | Rabbit ACLR model |
| Tian et al[40], 2018 | Baicalein | Rat TDSCs | Promote osteogenic differentiation | Activate the Wnt/β-catenin signaling pathway | Rat calcaneus-Achilles tendon injury model |
| Wang et al[41], 2016 | Icariin | Mouse MSCs | Promote osteogenic differentiation | Activate the Wnt/β-catenin signaling pathway | Mouse calvarial osteolysis model |
| Alipanah-Moghadam et al[42], 2023 | Andrographolide | Rat BMSCs | Increase cell resistance to environmental stress | Induce the expression of HO-1 | N/A |
| Tie et al[43], 2021 | Dedifferentiated | Rabbit BMSCs | Promote osteogenic differentiation | Activate the Nanog/NFATc1/OSX signaling pathway | Rabbit ACLR model |
| Díaz-Tocados et al[44], 2017 | Mg2+ | Rat BMSCs | Promote proliferation and osteogenic differentiation | Activate the Notch1 signaling pathway | Rat femur decellularized scaffold |
| Kim et al[45], 2015 | Static magnetic fields | Human BMSCs | Promote proliferation and osteogenic differentiation | Upregulate ALP, BSP-2, COL1A1, OCN, ON, OPN, OSX, and RUNX2 gene expression | N/A |
Table 2 Summary of biomaterial-enhanced stem cell therapy for tendon-bone healing
| Ref. | Biomaterial | Material type | Cell type | Functions | Model |
| Chen et al[47], 2020 | 3D-printed PLGA scaffolds | Conventional biological scaffolds | Rabbit BMSCs | Support cell growth and differentiation | Rabbit RCT model |
| Yea et al[48], 2020 | Hydroxyapatite-gradient scaffold | Conventional biological scaffolds | hUC-MSCs | Support cell adhesion, migration, and proliferation, promoting osteogenic and chondrogenic differentiation | Rat RCT model |
| Han et al[49], 2023 | CS-FS | Conventional biological scaffolds | Rabbit BMSCs and TSPCs | Enhance cell differentiation and activity, maintaining the phenotype | Rat and rabbit RCT models |
| Zhang et al[50], 2024 | Magnetically seeded biphasic scaffold | Conventional biological scaffolds | SPIO-BMSCs | Increase cell seeding efficiency, promote cell distribution and concentration, and enhance chondrogenic differentiation | Rat RCT model |
| Ji et al[53], 2023 | Cocktail-like gradient gelatin/hyaluronic acid | Hydrogel-based materials | Rat BMSCs | Simulate natural gradient structure, support long-term cell culture and embedding, promote cell growth and differentiation | Rat RCT model |
| Rothrauff et al[54], 2019 | Fibrin or GelMA | Hydrogel-based materials | Rat ADSC | Promote chondrogenic differentiation | Rat RCT model |
| McGoldrick et al[55], 2017 | ECM hydrogel | Hydrogel-based materials | Rat ADSC | Better biocompatibility, enhance repair efficacy | Rat calcaneus-Achilles tendon injury model |
| Shekaran et al[58], 2016 | ECM | Natural biomaterials | Human BMSCs | Promote cell proliferation and osteogenic differentiation | Mouse ectopic mineralization model |
| Deng et al[59], 2021 | ECM | Natural biomaterials | Human BMSCs | Promote macrophage secretion of osteoinductive factors, enhance osteogenic differentiation | Mouse femoral defect model |
| Mifune et al[61], 2013 | Cell sheets | Natural biomaterials | Human ACL-derived CD34+ cell | Increase proprioceptive recovery, graft maturation, and biomechanical strength | Rat ACLR model |
| Chang et al[62], 2012 | Cell sheets | Natural biomaterials | Rabbit PPCs | Maintain cell differentiation capacity, promote fibrocartilage formation | Rabbit ACLR model |
| Tang et al[63], 2020 | Cell sheets combined with acellular scaffolds | Natural biomaterials | Rabbit BMSCs | Promote cell differentiation, enhance new bone and fibrocartilage formation | Rabbit patella-patellar tendon injury model |
| Chen et al[64], 2020 | Cell sheets | Natural biomaterials | Canine USCs | Promote fibrocartilage formation, increase trabecular thickness and biomechanical strength | Canine RCT model |
| Matsumoto et al[65], 2021 | Cell sheets | Natural biomaterials | Human ADSCs | Bone tunnel narrowing, increased biomechanical strength | Rabbit ACLR model |
| Yao et al[66], 2023 | Cell sheets | Natural biomaterials | Rat TDSCs | Enhance bone formation and angiogenesis, regulate macrophage polarization and MMP/TIMP expression | Rat ACLR model |
| Wei et al[67], 2023 | Cell sheets | Natural biomaterials | LDSCs with BMP-2/TGF-β1 gene insertion | Promote osteogenic and tenogenic differentiation, improve biomechanical strength, enhance tissue maturation, inhibit bone tunnel widening | Mouse ACLR model |
Table 3 Limitations of mesenchymal stem cell therapy and main optimization strategies
| Limitations | Strategies | Functions |
| Low delivery efficiency | Biomaterials | Sustained release of MSCs, reduced degradation, preventing cell leakage, and prolonging retention at the injury site |
| Limited direct differentiation potential | Preconditioning/gene modification | Enhancing MSC differentiation towards bone, cartilage, tendon, and other tissues |
| Limited cell functionality | Preconditioning/gene modification | Boosting MSC proliferation, migration, angiogenesis, and immune modulation capabilities |
| Immunogenicity | Exosomes | Acellular therapies that eliminate cellular immunogenicity |
- Citation: Li H, Li ZP, Zhu MT, Lan CH, Wang YX, Liao P, Chen Z, Wang P, Sun JK, Shi Z, Lu PY, Lou C, Xu GH. Optimizing mesenchymal stem cell therapy for tendon-bone healing: Multifaceted approaches and future directions. World J Stem Cells 2025; 17(12): 114076
- URL: https://www.wjgnet.com/1948-0210/full/v17/i12/114076.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v17.i12.114076
